PURETECH HEALTH LLC

Class 005: PHARMACEUTICALS FOR THE TREATMENT OF COLLAGEN-MEDIATED DISORDERS; PHARMACEUTICALS FOR THE TREATMENT OF FIBROTIC-MEDIATED DISORDERS; PHARMACEUTICALS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES; Class 042: RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL, BIOTECHNOLOGY, AND DIGITAL MEDICINE FIELDS

Pharmaceutical products and preparations for treating solid tumors and hematological cancers; "ONCOLOGY"; Research and development in the pharmaceutical, biotechnology, and digital medicine fields

Oral, injectable, and inhaled pharmaceutical products and preparations for treating pulmonary disorders, fibrotic disorders, and rare diseases; Research and development in the pharmaceutical, biotechnology, and digital medicine fields

Pharmaceutical products and preparations for treating solid tumors and hematological cancers; "ONCOLOGY"; Research and development in the pharmaceutical, biotechnology, and digital medicine fields

Pharmaceutical products and preparations for treating solid tumors and hematological cancers; "THERAPEUTICS"; Research and development in the pharmaceutical, biotechnology, and digital medicine fields

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches; research and development in the pharmaceutical, biotechnology, and digital medicine fields

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches; research and development in the pharmaceutical, biotechnology, and digital medicine fields

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches; research and development in the pharmaceutical, biotechnology, and digital medicine fields

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches; "HEALTH"; research and development in the pharmaceutical, biotechnology, and digital medicine fields

financial management;[ financial consultation; investment consultation;] procurement of venture capital investment; financial investment in the field of scientific development businesses; formation, offering, and management of limited partnerships; office and plant location services for others; laboratory location services for others; business development services, namely, providing support for technological and scientific projects, start-ups, and advanced-stage business entities; [business consultation;] business planning; [business management consultation services, namely, financial, office, and personnel management for others;] market research; competitive product analysis; business networking, namely, introducing clients to potential business partners and investors and identification of strategic partnership and scientific partnership opportunities and product licensees; [consultation services in the field of licensing life sciences related products, namely, diagnostic, therapeutic and prophylactic products, software, and equipment related thereto;] executive employee recruitment; scientific personnel recruitment; accounting management; business networking in the scientific and research community; [scientific consultation; scientific research consultation;] identification of commercial technologies and products; new products; new product development [; consultation services in the field of licensing life sciences related intellectual property, namely, patents and processes]

House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches; "THERAPEUTICS"; research and development in the pharmaceutical, biotechnology, and digital medicine fields

Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases; commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields